- Home
- ZLAB vs PAX Comparison
ZLAB vs PAX Comparison
Compare ZLAB & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | PAX |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | China | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | PAX |
|---|---|---|
| Price | $19.77 | $10.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.60 | $18.00 |
| AVG Volume (30 Days) | ★ 888.8K | 798.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $12.99 |
| Revenue Next Year | $26.03 | $16.52 |
| P/E Ratio | ★ N/A | $25.65 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $10.56 |
| 52 Week High | $41.20 | $17.80 |
Technical Indicators
Market Signals| Indicator | ZLAB | PAX |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 42.60 |
| Support Level | $19.51 | $10.64 |
| Resistance Level | $20.25 | $11.95 |
| Average True Range (ATR) | 0.75 | 0.31 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 99.24 | 25.93 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.